Guidelines

The EAACI Guidelines provide evidence-based recommendations for your clinical practice on a variety of topics. These are formulated by multi-disciplinary working groups with a strong methodological base, aiming to provide indications and contraindications, identifying gaps in knowledge and/or implementation, unmet needs and future perspectives. EAACI Guidelines are a necessary resource with the goal of homogenizing clinical practice and provide the best treatment strategies for patients internationally. Read and implement them here!

All Guidelines

Filter

What are you looking for?

Category
- Aerobiology and pollution
- Allergen immunotherapy
- AllergoOncology
- Allergy asthma and a sport
- Allergy diagnosis
- Allied health and primary care
- Anaphylaxis
- Asthma
- Basic immunology
- Biologicals
- Comparative veterinary allergology
- COVID19
- Dermatology
- Drug allergy
- ENT
- Environmental allergy and climate change
- Eosinophilic esophagitis
- Epidemiology
- Epithelial cell biology
- Food allergy
- Food Allergy and Anaphylaxis
- Genomics and proteomics
- Immune deficiencies and autoimmunity
- Immunomodulation and nutrition
- Infections
- Mastocytosis and mast cells
- Microbiome
- Occupational allergy
- Ocular allergy
- OMIC Technologies in Allergy Research
- Pediatrics
- Prevention
- Systems medicine
- T2 Diseases
Year
- 2013
- 2014
- 2015
- 2016
- 2017
- 2019
- 2020
- 2021
- 2022
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abdominal pain
- ACE2
- Acoustic rhinometry
- acute respiratory tract infection
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- Adrenaline
- Adrenaline auto-injector
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- Air pollutant
- Air pollution
- Airborne enzyme
- AIT
- Algorithm
- allergen
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- Allergen-free foods
- allergen-immuntherapie
- allergens and epitopes
- Allergens and epitopes
- allergic asthma
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergie
- allergy
- Allergy diagnosis
- allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy management
- Allergy risk
- allergy test
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- Antiepileptic drugs hypersensitivity
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma control
- asthma exacerbations
- Asthma treatment
- Asthma treatment
- asymptomatic
- Atopic dermatitis
- atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- bacterial lysates
- Barrier
- Basic immunology
- Basic mechanisms
- basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- Bet v 1
- beta-lactam
- beta-lactam allergy
- Big data
- bigdata
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biologika
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- Bronchiolitis
- Bronchoconstriction
- BTK
- cabbage
- cancer
- cannabis allergy
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- child
- Childhood allergies
- childhoodvaccination
- children
- china
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- climate
- Clinical aspects
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical relevance
- clinicalimmunology
- Cluster analysis
- cofactors
- Collegen-binding receptor
- common cold
- community
- companion animals and pets
- Company Sponsored Symposia
- Component resolved diagnosis (CRD)
- Conjunctiva
- Consensus
- consensus document
- contact dermatitis
- Contact urticaria
- containment
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 vaccine
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactive molecules
- Cross-reactivity
- CRSwNP
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Deep learning
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- Differential diagnosis
- disease (CRD)
- disease burden
- disease transmission
- disinfection by-products
- DNase
- drug allergy
- Drug allergy
- Drug allergy diagnosis
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2022
- ECDA
- Education
- efficacy
- Egg allergy
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- ERS/EAACI
- EU
- exacerbations
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- experimental models
- exposome
- fermentedvegetable
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food
- food allergy
- Food allergy
- Food aversion
- Food processing
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- global atlas
- glycans
- grade
- Grant application
- guideline
- Guidelines
- Gut microbiota
- health economics
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- housedust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- IgE
- IL-37b
- immediate reactions
- Immune amnesia
- Immune deficiencies
- Immune health
- immune response
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immunity
- Innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- Kawasakisyndrome
- kimchi
- Lactobacillus
- learning methods
- ligelizumab
- lipid transfer protein
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTP
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- memory B cells
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- mHealth
- Microbiome
- microbiota
- microRNA
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- molecular allergology
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- multi-disciplinary management
- Multiple myeloma
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- neonates
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- newborns
- Next generation
- NLR
- non-immediate reactions
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- noninvasive diagnosis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- nutrients
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- Olfactory disturbance
- Olink
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral corticosteroids
- Oral immunotherapy
- outbreak
- Outcome measures
- Paediatrics
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient reported outcome
- patient-centered care
- peak expiratory flow
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Phenotype
- phenotypes
- Pine nut allergy
- PIPEline
- Placebo effect
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollution
- PRACTALL
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- preschool
- Prevention
- primary care
- Probiotic
- probiotics
- proresolvinglipids
- protection
- protectiveantibodies
- Proteotomics
- Proton pump inhibitor
- Psoriasis
- psychological effects
- pulmonary rehabilitation
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- regulation
- Regulatory aspects
- regulatory authorities
- RELEVANT
- Remodelling
- respiratory allergy
- Respiratory infections
- Rhinitis
- Rhinitis Monitoring
- rhinoconjuctivitis
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- safety
- SANI
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- SCIT
- self-care
- self‐management
- sensitization
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- SLIT
- smell
- SoMe
- Spirometry
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- supplementation
- survey
- Symptom scale
- Symptom score
- systematic review
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Tcells
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- Tree-nut allergy
- Tryptase
- UCARE
- umfrage
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria diagnosis
- urticaria treatment
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheezing
- white paper
- Xlinkedagammaglobulinemia
- young
- young adults
Author
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Alvarez-Cuesta, E
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Anna Pastorello, E.
- Annesi-Maesano, I.
- Antje Faber, M.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Arkhipova, S.
- Arnold, A.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Bachert, C.
- Baerenfaller, K.
- Ballmer-Weber, B.K.
- Barbaud, A.
- Barber, D.
- Bartel, S
- Bartra, J.
- Baumann, R
- Bavbek, S.
- Bazan-Socha, S.
- Beck, L.
- Bedbrook, A.
- Bégin, P.
- Beken, B.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Beyer, K.
- Bikov, A.
- Bindslev-Jensen, C.
- Birrell, F.
- Bisyuk, y.
- Bjermer, L.
- Blanca-Lopez, N.
- Blumchen, K.
- Boccabella, C.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Bosnic-Anticevich, S.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A
- Bozkurt, B.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Burks, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calder, V.
- Calderon, M
- Campbell, D.
- Canonica, G.W.
- Caruso, C.
- Castells, M.
- Caubet, J-C.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Cecchi, L.
- Chaker, A.
- Chan, E.
- Chawes, B.
- Chivato, T.
- Cianferoni, A.
- Clark, A.
- Clark, E.
- Clini, E.
- Cogo, A.
- Comberiati, P.
- Cornejo-Garcia, JA
- Correia-de-Sousa, J.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- de Blay, F.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P
- Descamps, V.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diaz Perales, A.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dramburg, S.
- Drijver-Messelink, MT
- du Toit, G.
- Duca, B.
- DunnGalvin, A.
- Durham, S.
- Ebo, D.G.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eiwegger, T.
- Elenius, V
- Emson, C.
- Erkekol, F.
- Eyerich, K.
- Faber, M.A.
- Farkas, H.
- Fauquert, J.
- Feketea, G.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Fieten, KB
- Figueras Alsius, M
- Firinu, D.
- Flokstra – de Blok, BMJ
- Flood, B.
- Florsheim, E.
- Fokkens, W.
- Forastiere, F.
- Fu, W.
- Garriga-Baraut, T.
- Garvey, LH
- Gelincik, A.
- Geng, B.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gevaert, P.
- Giménez-Arnau, A.
- Giovannini, M.
- Golding, M.
- Gomes, E.R.
- Gomez, F.
- González Díaz, S
- Goodman, R.
- Gore, C.
- Gowland, M.
- Greenhawt, M.
- Gunawardana, N.
- Gutermuth, J.
- Guttman, E.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Herth, F.
- Hilger, C.
- Hoffmann-Sommergruber, K.
- Hoffmann, H-J.
- Holgate, S.
- Holmdahl, I.
- Horvath, I.
- Howarth, P.
- Hox, V.
- Huang, Y
- Jackson, D.
- Jacobsen, L.
- Janda, J.
- Janson, C.
- Jeebhay, M.
- Jeimy, S.
- Jensen, B.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Jutel, M.
- K Chu, D.
- Kalayci, O.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kidon, M.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Konstantinopoulos, A.P.
- Korath, ADJ
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kündig, T.
- Kuyucu, S.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Lau, S.
- Lee, Y.
- Leonardi, A.
- Luengo, O.
- Macchia, L.
- Madrigal-Burgaleta, R.
- Mahler, V.
- Maleki, S.
- Malmberg, PL.
- Marrs, T.
- Martins, C.
- Maspero, J.
- Mathioudakis, A.
- Matricardi, P
- Matucci, A.
- Maurer, M.
- Mayorga, C.
- McSorley, H.
- Meyer, R.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Mukherjee, M.
- Muraro, A
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Nwaru, B.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ollert, M.
- Ong, P.Y.
- Pagani, M.
- Pali-Schöll, I
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pastorello, E.A.
- Pavord, I.
- Peden, D.
- Pepys, J.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pinnock, H.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Portelli, M.
- Qazi, K.
- Rabin, R.L.
- Radzikowska, U.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Riggioni, C.
- Ring, J.
- Roberts, G
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rossi, A.
- Rostaher, A.
- Rovati, GE
- Rudenko, M.
- Rukhadze, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Salapatek, A.
- Sanchez-Garcia, S.
- Sandoval-Ruballos, M.
- Santos, A.
- Scadding, G
- Scala, E.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schwarze, J.
- Sediva, A.
- Semernik, O.
- Shamji, M.H.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Song, K.
- Soyer, O.
- Spergel, J.
- Spolak-Bobryk, N.
- Stevens, W.
- Straumann, A.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Swoboda, I.
- Szajewska, H.
- Szymanski, L.
- Tan, B.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Till, S.J.
- Timmermans, F.
- Tonia, T.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Untersmayr, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- van Neerven, R.
- van Ree, R.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Vieths, S.
- Vlieg- Boerstra, B.
- von Mutius, E.
- Vultaggio, A.
- Walter, J.
- Wardzynska, A.
- Warner, A.
- Weidner, J.
- Werfel, T.
- Wiehn, E.
- Wong, C.
- Worm, M.
- Worm, M.
- Zhang, L.
- Zieglmayer, P.
- Zissler, UM
- Zuberbier, T.

Guideline 2022

Molecular Allergology User’s Guide 2.0
- Hoffmann-Sommergruber, K.
- de las Vecillas, L.
- et al
Read about this Guideline
Guideline 2022

Allergen Immunotherapy Guidelines Part 2: Recommendations
- Muraro, A
Read about this Guideline
Guideline 2022

Allergen Immunotherapy Guidelines Part 1: Systematic reviews
- Muraro, A
Read about this Guideline
Guideline 2022

EAACI guideline: Anaphylaxis (2021 update)
- Muraro, A
- Alviani, C.
- et al
Read about this Guideline
Guideline 2022

EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)
- Halken, S.
- de Silva, D.
- et al
Read about this Guideline
Guideline 2021

EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
- Agache, I.
- Akdis, C.A.
- et al
Read about this Guideline
Guideline 2020

EAACI Biologicals Guidelines – dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
- Agache, I.
- Akdis, C.A.
- et al
Read about this Guideline
Guideline 2020

EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
- Knibb, R.
- et al
Read about this Guideline
Guideline 2020

Efficacy and Safety of treatment with dupilumab for severe asthma A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma
- Agache, I.
Read about this Guideline
Guideline 2020

EAACI Biologicals Guidelines – Recommendations for severe asthma
- Agache, I.
Read about this Guideline
Guideline 2020

EAACI Guideline on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
Read about this Guideline
Guideline 2019

Allergen Immunotherapy Guidelines: House dustmite-driven allergic asthma
- Agache, I.
Read about this Guideline
Guideline 2016

Molecular allergology user’s guide
- Matricardi, P
Read about this Guideline

Show more Guidelines (1)

Guidelines

All Guidelines

What are you looking for?

Molecular Allergology User’s Guide 2.0

Allergen Immunotherapy Guidelines Part 2: Recommendations

Allergen Immunotherapy Guidelines Part 1: Systematic reviews

EAACI guideline: Anaphylaxis (2021 update)

EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)

EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

EAACI Biologicals Guidelines – dupilumab for children and adults with moderate‐to‐severe atopic dermatitis

EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma

Efficacy and Safety of treatment with dupilumab for severe asthma A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma

EAACI Biologicals Guidelines – Recommendations for severe asthma

EAACI Guideline on the effective transition of adolescents and young adults with allergy and asthma

Allergen Immunotherapy Guidelines: House dustmite-driven allergic asthma

Molecular allergology user’s guide